Sanofi-Aventis has had to take Inyx USA to court after it failed to
deliver on a contract manufacturing and supply agreement, a
situation that Aventis feared could "seriously harm its
interests". There may be important lessons...
Inyx Pharma has been given a new lease on life after it was bought by another UK firm, bringing relief after it was dragged into administration when its US parent company Inyx Inc. ran aground financially.
AstraZeneca has sold a manufacturing plant in France to a contract
manufacturer who will continue to supply the drug giant with its
products under a new outsourcing contract.
Singapore contract biologics manufacturer A-Bio has added another
top pharmaceutical company to its list of customers, just over 18
months after starting operations, reports Phil Taylor.
Singapore-based biologics contract manufacturer, A-Bio Pharma has
won its first contract after entering into a process development
and clinical supply service agreement with GlaxoSmithKline's
vaccine division, GlaxoSmithKline...
Australia's Mayne Pharma has bought its way into the European
market with the acquisition of a Germany company specialising in
the manufacture of freeze dried and solution vial products for
contract customers.
Cobra Biomanufacturing has granted AstraZeneca the right to use its
proprietary DNA manufacturing process to make nucleic acids for use
in its drug discovery operations.
Tablet-coating specialist BioProgress formalised its agreement with
US chemicals and machinery group FMC in deal that could be worth up
to $160 million (€128m) in revenues in the first six years.